Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans (Q34248284)

31 July 2017

title

Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

14 August 2023

author name string

P. E. Cryer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147094

14 August 2023

T. F. Tse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147094

14 August 2023

W. E. Clutter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147094

14 August 2023

S. D. Shah

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147094

14 August 2023

language of work or name

English

0 references

publication date

1 August 1984

1 reference

full work available at URL

31 July 2017

https://www.physiology.org/doi/pdf/10.1152/ajpendo.1984.247.2.E198

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

American Journal of Physiology

14 August 2023

published in

1 reference

31 July 2017

volume

247

1 reference

31 July 2017

issue

2 Pt 1

1 reference

31 July 2017

page(s)

E198-205

1 reference

Neural control of counter-regulatory events during glucopenia in man.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Glucose Counterregulation in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Epinephrine-induced insulin resistance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

The Control of Glycogen Metabolism in the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Effect of mannose, fructose and hydroxybutyrate on the hepatic response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Adrenergic mechanisms in the metabolic adaptation to fasting and feeding: effects of phlorizin on diet-induced changes in sympathoadrenal activity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Glucagon response to hypoglycemia in sympathectomized man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Initial splanchnic extraction of ingested glucose in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Persistent effect of sustained hyperglucagonemia on glucose production in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Blood Glucose Regulates the Effects of Insulin and Counterregulatory Hormones on Glucose Production In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Influence of Continuous Physiologic Hyperinsulinemia on Glucose Kinetics and Counterregulatory Hormones in Normal and Diabetic Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Homeostasis during hypoglycemia: central control of adrenal secretion and peripheral control of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.2.E198

Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog

14 August 2023

3

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Rdevance of Glucose Counterregulatory Systems to Patients with Diabetes: Critical Roles of Glucagon and Epinephrine

14 August 2023

6

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion

14 August 2023

12

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Physiologic Effects of Epinephrine on Glucose Turnover and Plasma Free Fatty Acid Concentrations Mediated Independently of Glucagon

14 August 2023

13

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man

14 August 2023

14

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Selective counterregulatory hormone responses after oral glucose in man

14 August 2023

17

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

14 August 2023

21

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man

14 August 2023

39

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

Glucose uptake and production during the oral glucose tolerance test

14 August 2023

42

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

The adrenomedullary and glucagon responses of hypopituitary children to insulin-induced hypoglycemia

14 August 2023

46

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.1984.247.2.E198

14 August 2023

Identifiers

0 references

1 reference